Results 171 to 180 of about 169,582 (297)

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

The Impact of Non-Steroidal Anti-inflammatory Drugs on Postoperative Outcomes in Posterior Spinal Surgery: A Systematic Review. [PDF]

Global Spine J
Singh R, Kopilak E, Rajan R, Bauer J, Razi AE, Ng M.   +5 more
europepmc   +1 more source

Non-steroidal anti-inflammatory drugs induced bronchial asthma and rhinitis [PDF]

, 2004
Faria, E
core  

The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions—A backward selection approach

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The quantitative effect of several inhibitory drugs on the development of adverse drug reactions (ADRs) is currently difficult to estimate. Our aim was to identify metabolic pathways, which, when inhibited, increase the risk for certain ADRs, and to use this system to consider comedication at individual level. Methods Data of a prospective
Judith Berres, Justyna Wozniak, Hannah Fölsch, Anja Knueppel‐Ruppert, Verena Graeff, Andrea Kriegisch‐Stumpf, Harald Dormann, Julia C. Stingl, Katja S. Just   +8 more
wiley   +1 more source

Central mechanisms of non-steroidal anti-inflammatory drugs analgesic effect

Научно-практическая ревматология, 2005
A. M. Balashov, I E Shahbasyan
doaj   +1 more source

Renal tubular acidosis complication of non-steroidal anti-inflammatory drugs induced interstitial nephritis and its complete resolution with steroids: A case report. [PDF]

World J Nephrol
Sinha Ray A, Errabelli P, Mareedu N, Lathiya MK.   +3 more
europepmc   +1 more source

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This work assessed the pharmacokinetics (PK), safety and tolerability of glasmacinal (EP395, an oral anti‐inflammatory macrolide with negligible antimicrobial activity in development for COPD treatment) in two healthy participant trials: ‘first‐in‐human’ (FIH) and ‘drug–drug‐interaction’ (DDI).
Dave Singh, Kate Hanrott, Olof Breuer, Johan Bylund, Björn Schultze, Virginia Norris   +5 more
wiley   +1 more source

Escleritis posterior: a propósito de un caso

Revista Cubana de Oftalmología
Las enfermedades inflamatorias de la esclera son infrecuentes. Involucran tanto la esclera como la epiesclera y se caracterizan por su cronicidad, dolor y por ser una causa potencial de ceguera.
Isabel Ambou Frutos, Ángeles Valdés Petitón, Carmen de Prada Sánchez, Lisette Pérez Sotolongo, Sandra Carvajal Reyes   +4 more
doaj  

Impact of non-steroidal anti-inflammatory drugs on malignant transformation in oral lichen planus: insights from a real-world cohort study. [PDF]

Front Pharmacol
Seebauer C, Ludwig R, Sieg P, Olbrich H, Curman P.   +4 more
europepmc   +1 more source